PROFUND ADVISORS LLC

Position in PCVX — Vaxcyte, Inc.

CIK 1129919 BETHESDA, MD

Position in PCVX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$1,876,262

-$238,709 QoQ

Shares Held

32,277

-11.3% QoQ

Ownership

0.022%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#142

of 329 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. PCVX ranks #16 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,398	$11,622,488
2	REGN	Regeneron Pharmaceuticals, Inc.	10,444	$6,512,251
3	ALNY	Alnylam Pharmaceuticals, Inc.	13,814	$4,158,428
4	MRNA	Moderna, Inc.	33,142	$2,320,934
5	APGE	Apogee Therapeutics, Inc.	17,163	$2,278,044
6	CYTK	Cytokinetics Inc	25,572	$2,178,478
7	KRYS	Krystal Biotech, Inc.	5,770	$2,144,535
8	KYMR	Kymera Therapeutics, Inc.	18,455	$2,116,234

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,876,262	32,277	-11.3%	Shares	Sole	2026-08-11
2026-03-31	$2,114,971	36,396	-27.9%	Shares	Sole	2026-04-27
2025-12-31	$2,327,624	50,447	+53.2%	Shares	Sole	2026-02-06
2025-09-30	$1,185,850	32,922	-6.2%	Shares	Sole	2025-11-06
2025-06-30	$1,140,710	35,088	+23.6%	Shares	Sole	2025-08-07
2025-03-31	$1,072,232	28,396	-4.9%	Shares	Sole	2025-05-08
2024-12-31	$2,443,848	29,854	+103.1%	Shares	Sole	2025-02-14
2024-09-30	$1,679,426	14,697	-22.6%	Shares	Sole	2024-11-14
2024-06-30	$1,433,708	18,987	-11.4%	Shares	Sole	2024-08-13
2024-03-31	$1,463,814	21,429	-21.4%	Shares	Sole	2024-05-08
2023-12-31	$1,713,184	27,280	-5.5%	Shares	Sole	2024-02-14
2023-09-30	$1,472,404	28,882	-6.8%	Shares	Sole	2023-11-13
2023-06-30	$1,548,339	31,004	-9.0%	Shares	Sole	2023-08-10
2023-03-31	$1,277,543	34,086	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.